Gene · 5699
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID-19 severity. | J Med Virol | 2023 | 36597912 | PubTator, text mining | PubMed |
| Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition. | Oncoimmunology | 2023 | 36531689 | PubTator, text mining | PubMed |
| Biomarkers predictive of response to pembrolizumab in head and neck cancer. | Cancer Med | 2023 | 36479637 | PubTator, text mining | PubMed |
| Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies. | Transplantation | 2023 | 36413151 | PubTator, text mining | PubMed |
| Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL. | Blood Adv | 2023 | 36385536 | PubTator, text mining | PubMed |
| CORUM: the comprehensive resource of mammalian protein complexes-2022. | Nucleic Acids Res | 2023 | 36382402 | PubTator, text mining | PubMed |
| T cell-inflamed gene expression profile is associated with favorable disease-specific survival in non-hypermutated microsatellite-stable colorectal cancer patients. | Cancer Med | 2023 | 36341526 | PubTator, text mining | PubMed |
| Bronchial gene expression alterations associated with radiological bronchiectasis. | Eur Respir J | 2023 | 36229050 | PubTator, text mining | PubMed |
| Retinal organoids provide unique insights into molecular signatures of inherited retinal disease throughout retinogenesis. | J Anat | 2023 | 36177499 | PubTator, text mining | PubMed |
| Identification of a pyroptosis-based model for predicting clinical outcomes from immunotherapy in patients with metastatic melanoma. | Cancer Med | 2023 | 36151761 | PubTator, text mining | PubMed |
| Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin. | Cell Mol Neurobiol | 2023 | 35896929 | PubTator, text mining | PubMed |
| Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. | Cell Biol Toxicol | 2023 | 34973136 | PubTator, text mining | PubMed |
| Modeling individual differences in the timing of change onset and offset. | Psychol Methods | 2023 | 34570554 | PubTator, text mining | PubMed |
| Investigation of the Utility of Multivariate Meta-Analysis Methods in Estimating the Summary Dose Response Curve. | J Res Health Sci | 2022 | 37571932 | PubTator, text mining | PubMed |
| IP-score correlated to endogenous tumour antigen peptide processing: A candidate clinical response score algorithm of immune checkpoint inhibitors therapy in multiple cohorts. | Front Immunol | 2022 | 36700205 | PubTator, text mining | PubMed |
| Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures. | Genes (Basel) | 2022 | 36672784 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I. | Ann Clin Case Rep | 2022 | 36626569 | PubTator, text mining | PubMed |
| Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis. | J Clin Med | 2022 | 36615128 | PubTator, text mining | PubMed |
| Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells. | J Immunother Cancer | 2022 | 36600602 | PubTator, text mining | PubMed |
| Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities. | Cells | 2022 | 36552827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5699/papers?page=10